Patents by Inventor Paul B. Yoo
Paul B. Yoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230381504Abstract: A method for treatment of incontinence by targeted nerve stimulation where a signal generator is provided to generate a stimulation signal to modulate a patient's voiding disorder having the symptoms of abnormal urgency, incontinence or retention. A stimulator targets a portion of the patient's nervous tissue where the nervous tissue may be the patient's saphenous nerve, the patient's lateral plantar nerve or the patient's medial plantar nerve. The stimulation signal is applied to the patient's nervous tissue to activate the nervous tissue in order to modulate the voiding disorder.Type: ApplicationFiled: August 10, 2023Publication date: November 30, 2023Inventors: PAUL B. YOO, MICHAEL SASHA JOHN
-
Patent number: 11752334Abstract: A method to treat a patient having a pelvic floor dysfunction by establishing a neurostimulator having a processor and a signal generator to generate a stimulation signal. The processor is set to one or more parameters effective in the treating of the patient's pelvic dysfunction when the stimulation signal is applied to a saphenous nerve of the patient. The neurostimulator is configured to provide the stimulation signal to a stimulator in accordance with a stimulation protocol. At least one stimulator is positioned next to a portion of the saphenous nerve of at least one lower limb of a patient. The processor is operationally activated to provide the stimulation signal to the stimulator for treatment of the patient.Type: GrantFiled: March 31, 2021Date of Patent: September 12, 2023Assignee: EBT Medical, Inc.Inventors: Paul B. Yoo, Michael Sasha John
-
Publication number: 20230256244Abstract: Methods and systems for improving nerve stimulation are disclosed which relate to shaping characteristics of the stimulation field such as by using different geometries and locations of stimulation. In embodiments, systems and methods are provided to improve selective modulation of specific targeted neural substrate, while minimizing the activation of adjacent non-targeted nervous tissue.Type: ApplicationFiled: April 25, 2023Publication date: August 17, 2023Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Patent number: 11633593Abstract: Methods and systems for improving nerve stimulation are disclosed which relate to shaping characteristics of the stimulation field such as by using different geometries and locations of stimulation. In embodiments, systems and methods are provided to improve selective modulation of specific targeted neural substrate, while minimizing the activation of adjacent non-targeted nervous tissue. While aspects of the disclosed technologies can be applied to any part of the central and peripheral nervous systems for treatment various disorders and providing symptom relief to provide for therapy related to pelvic floor disorders such as overactive bladder.Type: GrantFiled: January 6, 2020Date of Patent: April 25, 2023Assignee: EBT Medical, Inc.Inventors: Michael Sasha John, Paul B. Yoo
-
Publication number: 20230121038Abstract: A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.Type: ApplicationFiled: December 16, 2022Publication date: April 20, 2023Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Publication number: 20220409896Abstract: A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.Type: ApplicationFiled: August 30, 2022Publication date: December 29, 2022Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Patent number: 11529513Abstract: A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.Type: GrantFiled: May 5, 2020Date of Patent: December 20, 2022Assignee: EBT Medical, Inc.Inventors: Michael Sasha John, Paul B. Yoo
-
Patent number: 11446489Abstract: A method to treat a patient having a pelvic floor dysfunction by establishing a neurostimulator having a processor and a signal generator to generate a stimulation signal. The processor is set to one or more parameters effective in the treating of the patient's pelvic dysfunction when the stimulation signal is applied to a saphenous nerve of the patient. The neurostimulator is configured to provide the stimulation signal to a stimulator in accordance with a stimulation protocol. At least one stimulator is positioned next to a portion of the saphenous nerve of at least one lower limb of a patient. The processor is operationally activated to provide the stimulation signal to the stimulator for treatment of the patient.Type: GrantFiled: June 23, 2020Date of Patent: September 20, 2022Assignee: EBT Medical, Inc.Inventors: Paul B. Yoo, Michael Sasha John
-
Patent number: 11426579Abstract: A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.Type: GrantFiled: January 27, 2020Date of Patent: August 30, 2022Assignee: EBT Medical Inc.Inventors: Michael Sasha John, Paul B. Yoo
-
Publication number: 20220176118Abstract: Gamification for a pelvic disorder regimen has a processor for operating a control module configured to define a programmable treatment regimen. A neurostimulator is connected to the processor and the control module. The neurostimulator applies electrical or magnetic signals to the user according to the programmable treatment regimen which includes at least one treatment task to be performed by the user. A gramification module calculates and stores a set of scores of the user in performing at least one task defined in the programmable treatment program associated with one or more events defined in the programmable treatment program to provide a score assigned to each task performance. A user interface is connected to the control module and provides the user with information associated with the scores attained by the user.Type: ApplicationFiled: January 24, 2022Publication date: June 9, 2022Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Publication number: 20220143394Abstract: A method for screening a patient suffering from a urinary dysfunction for determining whether a patient is a viable candidate for therapy through the use of a neurostimulator. The neurostimulator is placed on the patient's skin and is operationally activated to transmit electrical or magnetic signals to a target nerve during therapy sessions held over an assessment time interval. During the therapy sessions, the patient provides therapeutic responses to the electrical or magnetic signals during the therapy sessions. Based upon the patient's therapeutic responses a determination is made to either implant the neurostimulator in the patient's body or to perform an alternative procedure.Type: ApplicationFiled: January 20, 2022Publication date: May 12, 2022Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Patent number: 11241573Abstract: Improved systems are disclosed for providing advantages during stimulation of peripheral nerves using transcutaneous, percutaneous, and implantable stimulators. Percutaneous stimulation is improved by accessories that guide the angel and depth of injection to allow for easy and controlled needle injection. Transcutaneous stimulation is improved using pressure to improve nerve recruitment. Systems and methods are disclosed for providing nerve stimulation of a patient to treat medical disorders and conditions within a single user or multiple user environments such as assisted living centers.Type: GrantFiled: November 16, 2018Date of Patent: February 8, 2022Assignee: EBT Medical, Inc.Inventors: Michael Sasha John, Paul B. Yoo
-
Patent number: 11229788Abstract: Nerve stimulation systems and methods are disclosed for providing improved compliance of a patient to a pelvic disorder treatment regimen. A patient interface module is connected to a control module for providing compliance information related to compliance criteria for a set of scheduled events. Patient compliance is assessed and notification or treatment events can be scheduled, rescheduled or otherwise adjusted based upon patient compliance or non-compliance according to compliance rules and parameters of a treatment compliance module. Both compliance and non-compliance may lead to adjustment of the treatment regimen, scheduled treatment events, and notifications to the patient or user operating the nerve stimulation system.Type: GrantFiled: March 12, 2021Date of Patent: January 25, 2022Assignee: EBT Medical, Inc.Inventors: Michael Sasha John, Paul B. Yoo
-
Publication number: 20220016413Abstract: Systems and methods for providing curated neurostimulation are disclosed such that users are enabled to provide improved therapy in a home environment. Stimulation protocols can be assessed to provide improved targeted stimulation of a nerve and less unwanted side effects. Sets of stimulation montages and associated weights are defined and are selected or adjusted in pre-defined using pre-defined operations that simplify adjustment of characteristics of the stimulation field such as the geometry and location of the provided stimulation. Stimulation matrix pads are arranged and activated to provide advantages. Strategies for adjusting the intensity of the stimulation field incorporate weighting values in non-primary channels and are disclosed. Curated neurostimulation can also include providing defined schedules for events and activities related to the therapy such as providing schedules for stimulation treatment, surveying a user, providing education and remote user support.Type: ApplicationFiled: July 14, 2021Publication date: January 20, 2022Inventors: MICHAEL SASHA JOHN, MIKE LABBE, KEITH R. CARLTON, PAUL B. YOO, SURANJAN ROYCHOWDHURY, TAMARA BAYNHAM, KEN W. MARIASH, DAVID LUBENSKY, JOHN LAI, BRIAN HOFFER, RACHEL LICHTE, JON LAWSON
-
Publication number: 20210379382Abstract: Methods for treating nocturia in a person are provided. The methods include assessing and identifying a person suffering from nocturia. A neurostimulator having a processor is connected to an electrical generator. The processor receives sensed data from the person and includes a sleep stimulation protocol. A determination is made as to whether the sensed data in cooperation with the sleep stimulation protocol indicates that a trigger event has occurred which defines a nocturia condition. When a trigger event has been determined, a therapy regimen provides electrical or magnetic stimulation to the leg of the person between the ankle and knee according to the sleep stimulation protocol.Type: ApplicationFiled: August 20, 2021Publication date: December 9, 2021Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Patent number: 11135428Abstract: Systems and methods provide notification to a user about pending neurostimulation or ongoing neurostimulation using a variety of notification signals and obtaining a user response to the notification using a variety of methods by which the user response is provided. Systems using implanted neurostimulation devices, external neurostimulators which provide transcutaneous electrical nerve stimulation, or both provide responsive and scheduled therapy regimens that include ecosystem support for augmenting user compliance when treating symptoms, conditions, or disorders. The system is also to assist the user through assessment protocols for improved customization of stimulus regimen attributes such as stimulation protocol parameter values, electrode montages, user surveying, and compliance contingent operations.Type: GrantFiled: July 2, 2018Date of Patent: October 5, 2021Assignee: EBT Medical, Inc.Inventors: Paul B. Yoo, Michael Sasha John
-
Publication number: 20210213283Abstract: A method to treat a patient having a pelvic floor dysfunction by establishing a neurostimulator having a processor and a signal generator to generate a stimulation signal. The processor is set to one or more parameters effective in the treating of the patient's pelvic dysfunction when the stimulation signal is applied to a saphenous nerve of the patient. The neurostimulator is configured to provide the stimulation signal to a stimulator in accordance with a stimulation protocol. At least one stimulator is positioned next to a portion of the saphenous nerve of at least one lower limb of a patient. The processor is operationally activated to provide the stimulation signal to the stimulator for treatment of the patient.Type: ApplicationFiled: March 31, 2021Publication date: July 15, 2021Inventors: PAUL B. YOO, MICHAEL SASHA JOHN
-
Patent number: 10946194Abstract: Nerve stimulation systems and methods are disclosed for providing improved compliance of a patient to a therapy regimen. Patient compliance is assessed and notification or treatment events can be scheduled, rescheduled or otherwise adjusted based upon patient compliance or non-compliance according to compliance rules and parameters of a treatment compliance module. Both compliance and non-compliance may lead to adjustment of the treatment regimen, scheduled treatment events, and notifications. Gamification of the treatment regimen allows users to obtain points that may be used to receive virtual awards, status awards, or monetary compensation of various forms. Monitoring of usage and compliance can be managed both locally and remotely from the user. Stimulation treatment, compliance monitoring, and gamification is disclosed for treatments using external or implanted stimulators, or the combination.Type: GrantFiled: December 20, 2018Date of Patent: March 16, 2021Assignee: EBT Medical, Inc.Inventors: Paul B. Yoo, Michael Sasha John
-
Publication number: 20200338347Abstract: Systems and methods provide stimulation of peripheral targets such as targets in the lower limbs. Electrode arrays realized in circumferential or longitudinal embodiments have pads with horizontal and/or vertical offsets. Electrode array geometries are customizable and adaptable to individual users and treatment of different disorders. Novel systems of customization include software and hardware implemented solutions. A single device can provide treatment of two or more disorders or unwanted states using selected electrode geometries and stimulation protocols. Systems and methods for assessment of candidate stimulation sites and protocols use subjective or objective measures or both to determine which meet stimulation success criteria. Simulation is provided using transcutaneous, percutaneous, or implantable stimulators. A main advantage is the improved treatment of pelvic floor disorders, and especially overactive bladder (OAB).Type: ApplicationFiled: July 8, 2020Publication date: October 29, 2020Inventors: MICHAEL SASHA JOHN, PAUL B. YOO
-
Publication number: 20200316379Abstract: A method to treat a patient having a pelvic floor dysfunction by establishing a neurostimulator having a processor and a signal generator to generate a stimulation signal. The processor is set to one or more parameters effective in the treating of the patient's pelvic dysfunction when the stimulation signal is applied to a saphenous nerve of the patient. The neurostimulator is configured to provide the stimulation signal to a stimulator in accordance with a stimulation protocol. At least one stimulator is positioned next to a portion of the saphenous nerve of at least one lower limb of a patient. The processor is operationally activated to provide the stimulation signal to the stimulator for treatment of the patient.Type: ApplicationFiled: June 23, 2020Publication date: October 8, 2020Inventors: PAUL B. YOO, MICHAEL SASHA JOHN